Therapeutic plasmapheresis and more specific methods of extracorporeal LDL-cholesterol elimination

Abstract

LDL-apheresis and hemorheopheresis can significantly reduce level of LDL-cholesterol in familial hypercholesterolemia (FH) if other therapy fails. Longterm therapy showed good toleration and low number of relevant side effects (5,6%).

Hemorheopheresis can additionaly increase blood flow in microcirculation in FH or other microcirculation disorders.

Keywords

• familial hyperlipoproteinemia
• LDL-apheresis
• extracorporeal elimination
• therapeutic hemapheresis
• hemorheopheresis